Prakiraan wutah bathi resik saben saham kanggo taun ngarep Inhibrx Biosciences Inc (INBX)

Logo korporat perusahaan Inhibrx Biosciences (INBX)

The expected annual EPS growth rate for the coming year reflects the forecast dynamics for Inhibrx Biosciences (INBX), where 6.20 represents the current metric level. Inhibrx Biosciences develops therapeutic proteins to combat cancer, aiming for long-term market dominance. The development of advanced antibodies enables the company to secure lucrative contracts with pharma behemoths. The current strategy relies on multi-specific drugs and the support of strategic partners.

Inhibrx Biosciences Inc (INBX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 15.11.2026

Ringkesan rincian data analitis Inhibrx Biosciences Inc (INBX)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Inhibrx Biosciences
Produk dadi Inhibrx

This indicator reflects the expert community's consensus forecast for earnings per share growth rates in the next period. Investors utilize this metric to assess business scalability potential and the sustainability of cash flows. By analyzing EPS growth prospects for the next fiscal year, one can evaluate the market's level of confidence in the scientific assets of Inhibrx Biosciences (INBX). A stable trajectory of the curve confirms institutional support for the company's therapeutic potential.

Analisis pesaing Inhibrx Biosciences

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Corp (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Pharma MNPR|I-Mab - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|FENC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep herontx.com|NVCT: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Coherus CHRS|Prakiraan wutah bathi saben saham kanggo taun ngarep CRBP|Prakiraan wutah bathi resik saben saham ing taun ngarep Cardiff Oncology CRDF|Prakiraan wutah bathi saben saham kanggo taun ngarep BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Lixte Biotechnology - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep CTXR (Citius Pharma)|Cellectar - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BLRX (BioLineRx Corp)|CANF: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Aprea (APRE)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep kaziatherapeutics.com|SLXN: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep NCNA|Prakiraan wutah bathi kanggo taun ngarep Chimerix Inc (CMRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kintara Therapeutics Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)